Reversible and tissue-specific activation of MAP kinase signaling by tamoxifen in Braf(V637)ER(T2) mice.
about
Development of an intein-mediated split-Cas9 system for gene therapyInfluenza A virus NS1 protein-induced JNK activation and apoptosis are not functionally linked.Multimode drug inducible CRISPR/Cas9 devices for transcriptional activation and genome editing.HIT-Cas9: A CRISPR/Cas9 Genome-Editing Device under Tight and Effective Drug Control
P2860
Reversible and tissue-specific activation of MAP kinase signaling by tamoxifen in Braf(V637)ER(T2) mice.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Reversible and tissue-specific activation of MAP kinase signaling by tamoxifen in Braf
@nl
Reversible and tissue-specific ...... ifen in Braf(V637)ER(T2) mice.
@en
type
label
Reversible and tissue-specific activation of MAP kinase signaling by tamoxifen in Braf
@nl
Reversible and tissue-specific ...... ifen in Braf(V637)ER(T2) mice.
@en
prefLabel
Reversible and tissue-specific activation of MAP kinase signaling by tamoxifen in Braf
@nl
Reversible and tissue-specific ...... ifen in Braf(V637)ER(T2) mice.
@en
P2860
P356
P1433
P1476
Reversible and tissue-specific ...... xifen in Braf(V637)ER(T2) mice
@en
P2093
Oskar Ortiz
Wolfgang Wurst
P2860
P304
P356
10.1002/DVG.22386
P50
P577
2013-03-28T00:00:00Z